Skip to main content
. 2019 Aug 28;13(5):842–854. doi: 10.1093/ckj/sfz095

Table 4.

Meta-analysis results for all three outcomes, shown separately for HD and non-HD patients

All-cause mortality [RR (95% CI) (I2)]
 CVD mortality [RR (95% CI) (I2)]
 CVD events [RR (95% CI) (I2)]
HD patients Non-HD patients HD patients Non-HD patients HD patients Non-HD patients
cIMTa

  • 1.08

  • (1.00–1.17)

  • (I2: 68%)

 NA

  • 1.29

  • (1.14–1.47)

  • (I2: 0%)

 NA NA NA
CACb

  • 2.51

  • (1.66–3.79)

  • (I2: 5.7%)

 NA NA NA

  • 3.77

  • (2.16–6.58)

  • (I2: 20.2%)

  • 4.02

  • (1.57–10.29)

  • (I2: 63.4%)
PWVb

  • 5.34

  • (3.01–9.47)

  • (I2: 0%)

  • 2.52

  • (1.40–4.55)

  • (I2: 62.6%)

  • 8.55

  • (4.37–94.39)

  • (I2: 0%)

 NA NA NA
PWVa

  • 1.25

  • (1.17–1.34)

  • (I2: 0%)

 NA

  • 1.24

  • (1.16–1.34)

  • (I2: 15.5%)

 NA NA NA
a

Per unit increase analysis.

b

Cut-off analysis.

NA, not enough data available to perform meta-analysis.